slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9.670 KRW | -1,73% | -4,64% | +3,09% |
Vakgebied
Aantal werknemers: 308
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceuticals Manufacturing
74,7
%
| 99 593 | 75,5 % | 105 549 | 74,7 % | +5,98% |
Pharmaceutical Wholesaler
15,7
%
| 23 225 | 17,6 % | 22 144 | 15,7 % | -4,65% |
Cosmetics and Medical Device Manufacturing
4,9
%
| 5 034 | 3,8 % | 6 891 | 4,9 % | +36,87% |
Pharmaceutical Raw Material Manufacturing
4,7
%
| 3 958 | 3,0 % | 6 694 | 4,7 % | +69,14% |
Medical Information System
0,1
%
| 102 | 0,1 % | 81 | 0,1 % | -20,03% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
91,0
%
| 117 086 | 88,8 % | 128 628 | 91,0 % | +9,86% |
Germany
4,9
%
| 5 034 | 3,8 % | 6 891 | 4,9 % | +36,87% |
Myanmar/Cambodia
1,5
%
| 2 105 | 1,6 % | 2 117 | 1,5 % | +0,59% |
Vietnam
1,0
%
| 640 | 0,5 % | 1 406 | 1,0 % | +119,61% |
Other
0,9
%
| 2 268 | 1,7 % | 1 226 | 0,9 % | -45,95% |
Ecuador/Bolivia
0,8
%
| 1 162 | 0,9 % | 1 085 | 0,8 % | -6,58% |
China
0,0
%
| 3 617 | 2,7 % | 6 | 0,0 % | -99,84% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Byung-Tae Noh
CEO | Chief Executive Officer | 62 | 15-12-85 |
Eun-Seok Kim
CEO | Chief Executive Officer | 48 | 01-02-08 |
Jae-Seong Na
DFI | Director of Finance/CFO | 55 | 01-02-93 |
Jae-Gwon Yang
CTO | Chief Tech/Sci/R&D Officer | 61 | 01-10-08 |
Sang-Tae Lee
BRD | Director/Board Member | 59 | 01-03-89 |
Shin-Won Bang
SAM | Sales & Marketing | 54 | - |
Tae-Hoon Kim
HRO | Human Resources Officer | 49 | 01-05-18 |
Boon-Yeon Ahn
PRN | Corporate Officer/Principal | 59 | 01-05-92 |
Nam-Soo Han
PRN | Corporate Officer/Principal | 68 | - |
Shin-Bae Ji
PRN | Corporate Officer/Principal | 60 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eun-Seok Kim
CEO | Chief Executive Officer | 48 | 01-02-08 |
Byung-Tae Noh
CEO | Chief Executive Officer | 62 | 15-12-85 |
Sang-Tae Lee
BRD | Director/Board Member | 59 | 01-03-89 |
Jae-Gwon Yang
CTO | Chief Tech/Sci/R&D Officer | 61 | 01-10-08 |
Jong-Il Kim
BRD | Director/Board Member | 62 | 24-03-17 |
Hye-Seon Jeong
BRD | Director/Board Member | 63 | 01-03-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 18 616 650 | 12 091 717 ( 64,95 %) | 1 100 000 ( 5,909 %) | 64,95 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
1 100 000 | 5.91% | 8 810 505 $ |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,09% | 127 mln. | |
+16,34% | 79,03 mld. | |
+8,29% | 8,78 mld. | |
-16,33% | 4,83 mld. | |
+51,22% | 4,65 mld. | |
+2,18% | 3,89 mld. | |
+20,51% | 2,34 mld. | |
-26,79% | 2,18 mld. | |
+15,12% | 2,11 mld. | |
-36,56% | 2 mld. |
- Beurs
- Aandelen
- Koers A067080
- Onderneming DAE HWA Pharmaceutical Co., Ltd.